Project Grant R01DK139324

Award Date 1/17/25
Completion Date 11/30/29
Dollars Obligated $731K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This $720,850 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to improve the validity of linked real-world data studies for diabetes mellitus research. The key objectives are to: 1) develop systematic approaches to investigate potential biases when using linked real-world data sources for comparative effectiveness and safety research of...
This federal Project Grant award of $248,915.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to unravel the role of epigenetics and cytokines in type 2 diabetes among African-ancestry populations. The grantee, the University of Maryland, Baltimore, will conduct this research project over a 3-year period from February 1, 2025 to January 31, 2028....
This federal Project Grant award of $340,175 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support a research project at American University to study the effects of federal funding for obesity prevention programs on weight-related health behaviors, obesity prevalence, and incidence of obesity-related chronic conditions. The project aims to leverage variation in...
This $211,590 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research on the real-time psychological and social influences on blood glucose management for adults with type 1 diabetes. The principal investigator at Carnegie Mellon University will conduct a 14-day ecological momentary assessment study combining survey data on mood,...
This federal Project Grant award for $614,420.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research supports a randomized trial to evaluate the effectiveness of the Diabetes Homeless Medication Support (D-HOMES) program on glycemic control among adults living with type 2 diabetes who have experienced homelessness. The 5-year study, conducted by the Hennepin Healthcare Research...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $608,855.00 to Indiana University to conduct research on improving assessments of physical activity and dietary intake data. The goal is to develop novel Bayesian approaches to survival analysis that can correct for measurement errors in these complex, high-dimensional datasets...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $526,902 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the University of California, Los Angeles (UCLA) with a period of performance from March 10, 2025 to February 28, 2029. The grant funds the development of novel statistical methods, computational algorithms, and user-friendly software to study individual health trajectories and disease progression using...
The federal Project Grant award, titled "SMARTSTART: A DIGITALLY-ENHANCED DIABETES SELF-MANAGEMENT INTERVENTION FOR LOW-INCOME PEOPLE NEWLY DIAGNOSED WITH TYPE 2 DIABETES", is funded by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research (CFDA 93.307) program. The $332,109 award to Arizona State University will support the development and delivery of a digital-enhanced diabetes self-management intervention...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to evaluate the impact of the Inflation Reduction Act's (IRA) insulin affordability provisions on Medicare beneficiaries. The $749,566 grant, effective January 1, 2025 through November 30, 2028, will leverage Medicare claims data and commercial insurance comparisons to assess the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $521,237 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Albert Einstein College of Medicine. The grant will fund a pilot, pragmatic, randomized trial to evaluate the feasibility, acceptability, and potential impact of integrating community health workers into an interdisciplinary chronic kidney disease clinic to address social determinants of...

This federal Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to address barriers that prevent equitable provision of guideline-recommended diabetes care in the United States. The $731,071 award, with an end date of November 30, 2029, will leverage real-world data from several large datasets to describe disparities in diabetes care and outcomes across individual, neighborhood, and insurance characteristics (Aim 1), examine associations between care receipt and outcomes using advanced analytical methods (Aim 2), and investigate physician perspectives on multilevel barriers to care (Aim 3). The project will involve collaboration between researchers at The Johns Hopkins University, the prime awardee, and sub-awardee New York University Grossman School of Medicine, which will contribute specialized expertise in pharmacoepidemiology and analysis of the Optum dataset.

Generated 4/29/25, 3:42 AM